MYCL-mediated reprogramming expands pancreatic insulin-producing cells

Michitada Hirano1, Yusei So1, Shin Tsunekawa2

  • 1Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

Nature Metabolism
|February 11, 2022
PubMed